Asymmetrex Issued U.S. Trademark Registration for Business Name

On April 5, the U.S. Patent and Trademark Office issued the trademark registration “Asymmetrex,” to stem cell biotechnology company Asymmetrex, LLC. The new trademark registration brands the company’s name for supplying testing and biomanufacturing services for therapeutic tissue stem cells used in stem cell research, stem cell treatments, and drug evaluations.  On April 5, 2022,

Asymmetrex Plans to Review Tissue Stem Cell Reports that Need Stem Cell Counting

Asymmetrex Plans to Review Tissue Stem Cell Reports That Need Stem Cell Counting

James L. Sherley, M.D., Ph.D., President and CEO of stem cell biotechnology Asymmetrex, says that it is time for his company to take a more active role in providing information on the opportunities missed when the stem cell medicine industry continues to treat patients without knowing the dosage of the stem cells. On September 8,

Asymmetrex Interviewed by SuperbCrew About New Web Portal With Tools for Therapeutic Stem Cell Applications

Asymmetrex Interviewed by SuperbCrew About New Web Portal With Tools for Therapeutic Stem Cell Applications

Last week on June 21 with the start of its participation in the virtual 2021 Annual Meeting of the International Society for Stem Cell Research, stem cell biotechnology company Asymmetrex launched a new web portal that provides scientists free online access to calculators for important parameters used in human tissue cell research.  In a June 30 post, business and technology news platform SuperbCrew interviewed Asymmetrex’s

Asymmetrex-Provides-Scientists-At-ISSCR-2021-Access-To-A-Missing-Critical-Quality-Attribute-For-Stem-Cell-Research-and-Medicine

Asymmetrex Provides Scientists At ISSCR 2021 Access To A Missing Critical Quality Attribute For Stem Cell Research and Medicine

Yesterday, June 23, stem cell biotechnology company Asymmetrex presented its latest advances in stem cell technology to attendees in the 2021 Annual Meeting of the International Society for Stem Cell Research, which runs from June 21-26.  The research presentation (Poster #345) highlighted applications in stem cell research and medicine for the company’s first-in-kind technology for quantifying therapeutic

Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting

Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting

Next week, June 21-26, stem cell biotechnology company Asymmetrex will participate as a presenter and an exhibitor in the 2021 Annual Meeting of the International Society for Stem Cell Research.  In an invited poster presentation (#345) and a company exhibitor display, Asymmetrex will introduce the virtual gathering of international stem cell scientists, physicians, and biotechnologists to

Asymmetrex Interviewed by SuperbCrew About Upcoming Presentations at ISSCR 2021

Asymmetrex Interviewed by SuperbCrew About Upcoming Presentations at ISSCR 2021

In a June 11 posting, online business and technology news portal SuperbCrew reported their recent interview with Asymmetrex President and CEO James L. Sherley, M.D., Ph.D. about the company’s upcoming first participation in an annual meeting of the International Society for Stem Cell Research. Asymmetrex’s exhibitor display and research poster #345 presentation in the virtual

Asymmetrex Stem Cell Strains for Immortal DNA Strand Research Featured by Kerafast

Asymmetrex Stem Cell Strains for Immortal DNA Strand Research Featured by Kerafast

Asymmetrex’s latest research report verifying the presence of immortal DNA strands in human tissue stem cells was featured by Kerafast. While other reports have verified immortal DNA strands in stem cells in species such as mold, plants, insects and mice, Asymmetrex’s new study is the first to describe the occurrence of immortal DNA strands in

Director James Sherley Interview with Superb Crew- Immortality and Stem Cells

Director James Sherley’s Interview with Superb Crew: Immortality and Stem Cells

Superb Crew interviewed Asymmetrex Director James Sherley to discuss the latest Asymmetrex report of a new advance on stem cell immortality. This interview goes into detail about how stem cell immortality is connected with kinetic stem cell counting, how it will impact the future of kinetic stem cell counting technology, and Asymmetrex’s connection to this